2,3,4,5-Tetramethoxyamphetamine
![]()  | |
| Systematic (IUPAC) name | |
|---|---|
| 
 1-(2,3,4,5-tetramethoxyphenyl)propan-2-amine  | |
| Clinical data | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
| ChemSpider | 
23206528  | 
| ChEMBL | 
CHEMBL124969  | 
| Chemical data | |
| Formula | C13H19NO4 | 
| Molar mass | 253.30 g·mol−1 | 
  | |
  | |
| (verify) | |
Tetramethoxyamphetamine, or 2,3,4,5-tetramethoxyamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. Tetramethoxyamphetamine was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg, and the duration unknown. Tetramethoxyamphetamine produces a threshold, mydriasis, and a headache. Very little data exists about its pharmacological properties, metabolism, and toxicity.
External links
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
